Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
PDGFRB | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 2.32E5 | Evidence | O | ||||
PDGFRB | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 1.37E5 | Evidence | |||||
PDGFRB | CRKL | CRKL: Crk-like protein | 1.22E5 | Evidence | |||||
PDGFRB | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 1.21E5 | Evidence | |||||
PDGFRB | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 9.66E4 | Evidence | |||||
PDGFRB | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 8.52E4 | Evidence | |||||
PDGFRB | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 7.21E4 | Evidence | O | ||||
PDGFRB | VAV1 | VAV1, VAV: Proto-oncogene vav | 6.45E4 | Evidence | |||||
PDGFRB | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 6.45E4 | Evidence | |||||
PDGFRB | FRK | FRK, PTK5, RAK: Tyrosine-protein kinase FRK | 6.35E4 | Evidence | |||||
PDGFRB | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 6.35E4 | Evidence | |||||
PDGFRB | HCK | N/A | 5.72E4 | Evidence | |||||
PDGFRB | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 5.72E4 | Evidence | |||||
PDGFRB | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 5.32E4 | Evidence | |||||
PDGFRB | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 4.20E4 | Evidence | |||||
PDGFRB | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 3.47E4 | Evidence | O | ||||
PDGFRB | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 3.38E4 | Evidence | |||||
PDGFRB | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 3.15E4 | Evidence | |||||
PDGFRB | GRAP | GRAP: GRB2-related adapter protein | 3.04E4 | Evidence | |||||
PDGFRB | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 2.57E4 | Evidence | |||||
PDGFRB | KIT | KIT: Mast/stem cell growth factor receptor precursor | 2.57E4 | Evidence | |||||
PDGFRB | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 2.27E4 | Evidence | |||||
PDGFRB | FRS3 | FRS3: Fibroblast growth factor receptor substrate 3 | 1.92E4 | Evidence | |||||
PDGFRB | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 1.88E4 | Evidence | |||||
PDGFRB | JUP | JUP, CTNNG, DP3: Junction plakoglobin | 8.68E3 | Evidence | |||||
PDGFRB | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 3.62E3 | Evidence | |||||
PDGFRB | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 1.50E3 | Evidence | |||||
PDGFRB | NCK2 | NCK2: Cytoplasmic protein NCK2 | 519.0 | Evidence | O | ||||
PDGFRB | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 258.0 | Evidence | |||||
PDGFRB | FIGF | FIGF, VEGFD: Vascular endothelial growth factor D precursor | 245.0 | Evidence | |||||
PDGFRB | GRAP2 | GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 | 243.0 | Evidence | |||||
PDGFRB | PLCG2 | PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 | 230.0 | Evidence | |||||
PDGFRB | SLA2 | SLA2, C20orf156, SLAP2: Src-like-adapter 2 | 224.0 | Evidence | |||||
PDGFRB | LNK | SH2B3, LNK: SH2B adapter protein 3 | 224.0 | Evidence | |||||
PDGFRB | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 224.0 | Evidence | |||||
PDGFRB | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 224.0 | Evidence | |||||
PDGFRB | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 224.0 | Evidence | |||||
PDGFRB | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 209.0 | Evidence | |||||
PDGFRB | BMX | N/A | 206.0 | Evidence | |||||
PDGFRB | STAT3 | 200.0 | Evidence | ||||||
PDGFRB | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 167.0 | Evidence | |||||
PDGFRB | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 167.0 | Evidence | |||||
PDGFRB | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 149.0 | Evidence | |||||
PDGFRB | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 149.0 | Evidence | |||||
PDGFRB | SYK | SYK: Tyrosine-protein kinase SYK | 149.0 | Evidence | |||||
PDGFRB | JAK1 | 147.0 | Evidence | ||||||
PDGFRB | TXK | TXK, PTK4: Tyrosine-protein kinase TXK | 147.0 | Evidence | |||||
PDGFRB | GRB10 | N/A | 141.0 | Evidence | |||||
PDGFRB | CRK | CRK: Proto-oncogene C-crk | 141.0 | Evidence | |||||
PDGFRB | APS | SH2B2, APS: SH2B adapter protein 2 | 134.0 | Evidence | |||||
PDGFRB | CSK | CSK: Tyrosine-protein kinase CSK | 134.0 | Evidence | |||||
PDGFRB | LYN | LYN: Tyrosine-protein kinase Lyn | 134.0 | Evidence | |||||
PDGFRB | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 132.0 | Evidence | |||||
PDGFRB | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 132.0 | Evidence | |||||
PDGFRB | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 132.0 | Evidence | |||||
PDGFRB | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 119.0 | Evidence | |||||
PDGFRB | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 112.0 | Evidence | |||||
PDGFRB | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 90.70 | Evidence | |||||
PDGFRB | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 89.30 | Evidence | |||||
PDGFRB | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 82.40 | Evidence | |||||
PDGFRB | CBLC | CBLC, CBL3, RNF57: Signal transduction protein CBL-C | 81.20 | Evidence | |||||
PDGFRB | PTK6 | PTK6, BRK: Tyrosine-protein kinase 6 | 80.50 | Evidence | |||||
PDGFRB | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 73.20 | Evidence | |||||
PDGFRB | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 72.70 | Evidence | |||||
PDGFRB | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 64.10 | Evidence | |||||
PDGFRB | FER | FER, TYK3: Proto-oncogene tyrosine-protein kinase FER | 59.60 | Evidence | |||||
PDGFRB | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 57.50 | Evidence | |||||
PDGFRB | BRDG1 | STAP1, BRDG1: Signal-transducing adaptor protein 1 | 49.70 | Evidence | |||||
PDGFRB | CNN3 | CNN3: Calponin-3 | 46.30 | Evidence | |||||
PDGFRB | GHR | GHR: Growth hormone receptor precursor | 43.60 | Evidence | |||||
PDGFRB | ITGAV | ITGAV, MSK8, VNRA: Integrin alpha-V precursor | 39.10 | Evidence | |||||
PDGFRB | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 39.10 | Evidence | |||||
PDGFRB | GNA11 | GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 | 38.00 | Evidence | |||||
PDGFRB | IGFBP7 | IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor | 37.90 | Evidence | |||||
PDGFRB | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 37.80 | Evidence | |||||
PDGFRB | FGFR1 | FGFR1, FGFBR, FLG, FLT2: Basic fibroblast growth factor receptor 1 precursor | 37.80 | Evidence | |||||
PDGFRB | KIR3DL1 | N/A | 37.80 | Evidence | |||||
PDGFRB | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 37.80 | Evidence | |||||
PDGFRB | FGFR3 | FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor | 37.80 | Evidence | |||||
PDGFRB | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 37.80 | Evidence | |||||
PDGFRB | TRPV4 | TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb | 37.80 | Evidence | |||||
PDGFRB | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 37.80 | Evidence | |||||
PDGFRB | ADAM15 | ADAM15, MDC15: ADAM 15 precursor | 37.80 | Evidence | |||||
PDGFRB | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 37.80 | Evidence | |||||
PDGFRB | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 37.80 | Evidence | |||||
PDGFRB | GRB14 | GRB14: Growth factor receptor-bound protein 14 | 37.10 | Evidence | O | ||||
PDGFRB | GRB7 | GRB7: Growth factor receptor-bound protein 7 | 37.10 | Evidence | |||||
PDGFRB | MERTK | MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor | 34.80 | Evidence | |||||
PDGFRB | DAB2 | DAB2, DOC2: Disabled homolog 2 | 33.90 | Evidence | |||||
PDGFRB | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 33.90 | Evidence | |||||
PDGFRB | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 33.90 | Evidence | |||||
PDGFRB | PTPRF | PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor | 33.90 | Evidence | |||||
PDGFRB | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 33.90 | Evidence | |||||
PDGFRB | CNTN1 | CNTN1: Contactin-1 precursor | 33.90 | Evidence | |||||
PDGFRB | EPHA8 | EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor | 33.90 | Evidence | |||||
PDGFRB | TRPM7 | TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me | 33.90 | Evidence | |||||
PDGFRB | ATRN | N/A | 33.90 | Evidence | |||||
PDGFRB | SHB | SHB: SH2 domain-containing adapter protein B | 33.20 | Evidence | O | ||||
PDGFRB | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 32.70 | Evidence | O | ||||
PDGFRB | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 31.20 | Evidence | |||||
PDGFRB | EPHB3 | EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor | 31.20 | Evidence | |||||
PDGFRB | INSR | INSR: Insulin receptor precursor | 31.20 | Evidence | |||||
PDGFRB | EPHB2 | EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor | 31.20 | Evidence | |||||
PDGFRB | SH2D1A | SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A | 29.40 | Evidence | |||||
PDGFRB | AGTR1 | AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor | 29.00 | Evidence | |||||
PDGFRB | IRS1 | IRS1: Insulin receptor substrate 1 | 28.70 | Evidence | |||||
PDGFRB | CTTN | CTTN, EMS1: Src substrate cortactin | 28.70 | Evidence | |||||
PDGFRB | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 28.20 | Evidence | |||||
PDGFRB | PRLR | PRLR: Prolactin receptor precursor | 28.20 | Evidence | |||||
PDGFRB | THY1 | THY1: Thy-1 membrane glycoprotein precursor | 28.20 | Evidence | |||||
PDGFRB | MET | MET: Hepatocyte growth factor receptor precursor | 28.20 | Evidence | |||||
PDGFRB | EGF | EGF: Pro-epidermal growth factor precursor | 28.20 | Evidence | |||||
PDGFRB | PTPN1 | PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 | 28.20 | Evidence | |||||
PDGFRB | IL12RB2 | IL12RB2: Interleukin-12 receptor beta-2 chain precursor | 28.20 | Evidence | |||||
PDGFRB | SCARB2 | SCARB2, CD36L2, LIMPII: Lysosome membrane protein 2 | 26.00 | Evidence | |||||
PDGFRB | SHC2 | N/A | 25.70 | Evidence | |||||
PDGFRB | FABP4 | FABP4: Fatty acid-binding protein, adipocyte | 25.50 | Evidence | |||||
PDGFRB | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 25.3 | Evidence | |||||
PDGFRB | ITGB3 | ITGB3, GP3A: Integrin beta-3 precursor | 25.3 | Evidence | |||||
PDGFRB | EPHB1 | EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor | 25.3 | Evidence | |||||
PDGFRB | ICAM3 | ICAM3: Intercellular adhesion molecule 3 precursor | 25.20 | Evidence | |||||
PDGFRB | CD58 | CD58, LFA3: Lymphocyte function-associated antigen 3 precursor | 25.20 | Evidence | |||||
PDGFRB | MAG | MAG, GMA: Myelin-associated glycoprotein precursor | 25.20 | Evidence | |||||
PDGFRB | CD3D | CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor | 25.20 | Evidence | |||||
PDGFRB | PSCD1 | PSCD1, D17S811E: Cytohesin-1 | 24.90 | Evidence | |||||
PDGFRB | NEDD9 | NEDD9, CASL: Enhancer of filamentation 1 | 24.90 | Evidence | |||||
PDGFRB | ABI1 | ABI1, SSH3BP1: Abl interactor 1 | 24.90 | Evidence | |||||
PDGFRB | SNCA | SNCA, NACP, PARK1: Alpha-synuclein | 24.90 | Evidence | |||||
PDGFRB | CD1A | CD1A: T-cell surface glycoprotein CD1a precursor | 24.80 | Evidence | |||||
PDGFRB | CD28 | CD28: T-cell-specific surface glycoprotein CD28 precursor | 24.80 | Evidence | |||||
PDGFRB | ITGB4 | N/A | 24.80 | Evidence | |||||
PDGFRB | NCAM1 | NCAM1, NCAM: Neural cell adhesion molecule 1, 140 kDa isoform precursor | 24.80 | Evidence | |||||
PDGFRB | IFNGR1 | IFNGR1: Interferon-gamma receptor alpha chain precursor | 24.80 | Evidence | |||||
PDGFRB | EPOR | EPOR: Erythropoietin receptor precursor | 24.80 | Evidence | |||||
PDGFRB | ERBB4 | ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor | 24.80 | Evidence | |||||
PDGFRB | TNNC1 | TNNC1, TNNC: Troponin C, slow skeletal and cardiac muscles | 22.90 | Evidence | |||||
PDGFRB | IL4R | IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor | 22.90 | Evidence | |||||
PDGFRB | LEPR | LEPR, DB, OBR: Leptin receptor precursor | 22.90 | Evidence | |||||
PDGFRB | CD4 | CD4: T-cell surface glycoprotein CD4 precursor | 22.40 | Evidence | |||||
PDGFRB | HLA-C | HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor | 22.40 | Evidence | |||||
PDGFRB | SLAMF1 | SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor | 22.40 | Evidence | |||||
PDGFRB | HLA-DMB | HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec | 22.40 | Evidence | |||||
PDGFRB | CD22 | CD22, SIGLEC2: B-cell receptor CD22 precursor | 22.40 | Evidence | |||||
PDGFRB | CD79A | CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain | 22.40 | Evidence | |||||
PDGFRB | CD3E | CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor | 22.40 | Evidence | |||||
PDGFRB | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 22.40 | Evidence | |||||
PDGFRB | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 22.30 | Evidence | |||||
PDGFRB | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 22.30 | Evidence | |||||
PDGFRB | SH3KBP1 | SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 | 22.30 | Evidence | |||||
PDGFRB | AP1GBP1 | AP1GBP1, SYNG: AP1 subunit gamma-binding protein 1 | 22.30 | Evidence | |||||
PDGFRB | ASGR1 | ASGR1: Asialoglycoprotein receptor 1 | 22.20 | Evidence | |||||
PDGFRB | EPHA2 | EPHA2, ECK: Ephrin type-A receptor 2 precursor | 22.20 | Evidence | |||||
PDGFRB | DCC | DCC: Netrin receptor DCC precursor | 22.20 | Evidence | |||||
PDGFRB | EPHA4 | EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor | 22.20 | Evidence | |||||
PDGFRB | ROBO1 | ROBO1, DUTT1: Roundabout homolog 1 precursor | 22.20 | Evidence | |||||
PDGFRB | SNTA1 | SNTA1, SNT1: Alpha-1-syntrophin | 20.50 | Evidence | |||||
PDGFRB | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 20.50 | Evidence | |||||
PDGFRB | CNTN2 | CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor | 20.00 | Evidence | |||||
PDGFRB | FLT3 | FLT3, STK1: FL cytokine receptor precursor | 20.00 | Evidence | |||||
PDGFRB | CAV1 | CAV1, CAV: Caveolin-1 | 19.50 | Evidence | |||||
PDGFRB | LAT | LAT: Linker for activation of T-cells family member 1 | 19.10 | Evidence | |||||
PDGFRB | CCR2 | CCR2, CMKBR2: C-C chemokine receptor type 2 | 19.10 | Evidence | |||||
PDGFRB | PLAUR | PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor | 19.10 | Evidence | |||||
PDGFRB | FGFR4 | FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor | 18.90 | Evidence | |||||
PDGFRB | GNAI1 | GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit | 18.60 | Evidence | |||||
PDGFRB | PDGFA | PDGFA, PDGF1: Platelet-derived growth factor A chain precursor | 18.60 | Evidence | |||||
PDGFRB | CXCL5 | CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor | 18.60 | Evidence | |||||
PDGFRB | LIF | LIF, HILDA: Leukemia inhibitory factor precursor | 18.60 | Evidence | |||||
PDGFRB | CSH2 | GH1: Somatotropin precursor | 18.60 | Evidence | |||||
PDGFRB | S100A11 | MLN70, S100A11, S100C: Protein S100-A11 | 18.60 | Evidence | |||||
PDGFRB | CXCL1 | CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor | 18.60 | Evidence | |||||
PDGFRB | IRS4 | IRS4, RP6-24A23.4-001, hCG_20762: Insulin receptor substrate 4 | 18.60 | Evidence | |||||
PDGFRB | TNFRSF1A | TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre | 17.50 | Evidence | |||||
PDGFRB | TIMP2 | TIMP2: Metalloproteinase inhibitor 2 precursor | 17.20 | Evidence | |||||
PDGFRB | MPL | MPL, TPOR: Thrombopoietin receptor precursor | 17.10 | Evidence | |||||
PDGFRB | ATP2A2 | ATP2A2, ATP2B: Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 17.10 | Evidence | |||||
PDGFRB | GNAI3 | GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha | 16.7 | Evidence | |||||
PDGFRB | MYL4 | MYL4, MLC1, PRO1957: Myosin light polypeptide 4 | 16.60 | Evidence | |||||
PDGFRB | PLD2 | PLD2: Phospholipase D2 | 16.60 | Evidence | |||||
PDGFRB | SH3BP5 | N/A | 16.60 | Evidence | |||||
PDGFRB | ACP1 | ACP1: Low molecular weight phosphotyrosine protein phosphatase | 16.60 | Evidence | |||||
PDGFRB | IRS2 | IRS2: Insulin receptor substrate 2 | 16.40 | Evidence | |||||
PDGFRB | IL1B | IL1B, IL1F2: Interleukin-1 beta precursor | 16.40 | Evidence | |||||
PDGFRB | MCF2 | MCF2, DBL: Proto-oncogene DBL | 16.40 | Evidence | |||||
PDGFRB | GAB1 | GAB1: GRB2-associated-binding protein 1 | 16.40 | Evidence | |||||
PDGFRB | CETN1 | CETN1, CEN1, CETN: Centrin-1 | 15.70 | Evidence | |||||
PDGFRB | LILRB1 | N/A | 15.30 | Evidence | |||||
PDGFRB | ITSN1 | ITSN1, ITSN, SH3D1A: Intersectin-1 | 15.10 | Evidence | |||||
PDGFRB | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 14.90 | Evidence | |||||
PDGFRB | EHD1 | EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 | 14.90 | Evidence | |||||
PDGFRB | PIK3CB | PIK3CB, PIK3C1: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit | 14.90 | Evidence | |||||
PDGFRB | CD2AP | CD2AP: CD2-associated protein | 14.90 | Evidence | |||||
PDGFRB | LCP1 | LCP1, PLS2: Plastin-2 | 14.90 | Evidence | |||||
PDGFRB | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 14.90 | Evidence | |||||
PDGFRB | SPTA1 | SPTA1, SPTA: Spectrin alpha chain, erythrocyte | 14.70 | Evidence | |||||
PDGFRB | MMP13 | MMP13: Collagenase 3 precursor | 14.70 | Evidence | |||||
PDGFRB | DAB1 | DAB1: Disabled homolog 1 | 14.60 | Evidence | |||||
PDGFRB | PTPN12 | PTPN12: Tyrosine-protein phosphatase non-receptor type 12 | 14.60 | Evidence | |||||
PDGFRB | BMP7 | BMP7, OP1: Bone morphogenetic protein 7 precursor | 14.60 | Evidence | |||||
PDGFRB | HPCAL1 | HPCAL1, BDR1: Hippocalcin-like protein 1 | 14.60 | Evidence | |||||
PDGFRB | STAM2 | STAM2: Signal transducing adapter molecule 2 | 14.60 | Evidence | |||||
PDGFRB | NGFR | NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor | 14.20 | Evidence | |||||
PDGFRB | FASLG | FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 | 14.20 | Evidence | |||||
PDGFRB | H2-ALPHA | TUBA3C, TUBA2, TUBA3D: Tubulin alpha-3C/D chain | 14.10 | Evidence | |||||
PDGFRB | HLA-DMA | DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP | 13.50 | Evidence | |||||
PDGFRB | HLA-A | HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor | 13.50 | Evidence | |||||
PDGFRB | CNN1 | CNN1: Calponin-1 | 13.50 | Evidence | |||||
PDGFRB | LATS2 | LATS2, KPM: Serine/threonine-protein kinase LATS2 | 13.50 | Evidence | |||||
PDGFRB | ARHGEF7 | N/A | 13.50 | Evidence | |||||
PDGFRB | PIK3CG | PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i | 13.20 | Evidence | |||||
PDGFRB | RPS6KA5 | RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 | 13.20 | Evidence | |||||
PDGFRB | ELMO2 | ELMO2, CED12A, KIAA1834: Engulfment and cell motility protein 2 | 13.20 | Evidence | |||||
PDGFRB | CNKSR2 | CNKSR2, CNK2, KIAA0902, KSR2: Connector enhancer of kinase suppressor of ras 2 | 13.20 | Evidence | |||||
PDGFRB | DOK1 | DOK1: Docking protein 1 | 13.20 | Evidence | |||||
PDGFRB | TGFBR1 | TGFBR1: TGF-beta receptor type-1 precursor | 12.70 | Evidence | |||||
PDGFRB | CD36 | CD36, GP3B, GP4: Platelet glycoprotein 4 | 12.70 | Evidence | |||||
PDGFRB | CCR5 | CCR5: CCR5 receptor (Fragment) | 12.70 | Evidence | |||||
PDGFRB | CD5 | CD5, LEU1: T-cell surface glycoprotein CD5 precursor | 12.70 | Evidence | |||||
PDGFRB | CXCR4 | CXCR4: C-X-C chemokine receptor type 4 | 12.70 | Evidence | |||||
PDGFRB | CD44 | N/A | 12.50 | Evidence |